Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation while sparing healthy tissues.
By using a KRAS-targeting drug to mark cancer cells and attaching a radioactive antibody to eliminate them, this approach has successfully wiped out tumors in mice without the usual side effects of radiation.
Targeted Radiation: A Breakthrough in Cancer Treatment
Radiation is one of the most powerful tools for destroying tumors, but traditional radiation therapy can’t distinguish between cancerous and healthy cells, often causing harmful side effects.
Now, researchers at UC San Francisco have developed a way to make radiation more precise. Their new approach combines a specialized drug that marks cancer cells with a radioactive antibody that directly targets and destroys them.
In studies on mice, this treatment successfully eliminated bladder and lung tumors without causing common radiation side effects like lethargy or weight loss.
“This is a one-two punch,” said Charly Craik, PhD, a professor of pharmaceutical chemistry at UCSF and co-senior author of the study, published recently in the journal Cancer Research. “We could potentially kill the tumors before they can develop resistance.”
A Cancer Drug Becomes a Molecular Flag
The foundation for this breakthrough was laid a decade ago when UCSF’s Kevan Shokat, PhD, discovered how to target KRAS, a notorious cancer-causing protein. When mutated, KRAS drives uncontrolled cell growth and is responsible for up to a third of all cancers.
Shokat’s breakthrough led to the development of drugs that latched onto cancerous KRAS. But the drugs could only shrink tumors for a few months before the cancer came roaring back.
The drugs stayed bound to KRAS, however, and Craik, wondered whether they might make cancer cells more “visible” to the immune system.
“We suspected early on that the KRAS drugs might serve as permanent flags for cancer cells,” Craik said.
Harnessing Radiation for Precision Therapy
In 2022, a UCSF team that included Craik and Shokat demonstrated this was indeed possible.
The team designed an antibody that recognized the unique drug/KRAS surface fragment and beckoned to immune cells.
However, the approach needed the immune system to have the strength to beat the cancer by itself, which turned out not to be that effective.
Bringing Atomic-Level Radiation to Cancer Cells
Around the same time, Craik began working with Mike Evans, PhD, a professor of radiology at UCSF, to develop a different approach to destroy cancer cells.
They still used the K-RAS drug to flag cancerous cells, but this time they armed the antibodies with radioactive payloads.
The combination worked, eliminating lung cancer in mice with minimal side effects.
“Radiation is ruthlessly efficient in its ability to ablate cancer cells, and with this approach, we’ve shown that we can direct it exclusively to those cancers,” Evans said.
Added Craik, “The beauty of this approach is that we can calculate an extremely safe dose of radiation. Unlike external beam radiation, this method uses only the amount of radiation needed to beat the cancer.”
Customizing Treatment for More Patients
To make this therapy work in most patients, scientists will have to develop antibodies that account for the different ways that people’s cells display KRAS.
The UCSF team is now working on this – motivated by their own evidence that it can work.
Kliment Verba, PhD, an assistant professor of cellular and molecular pharmacology at UCSF, used cryo-electron microscopy to visualize the ‘radiation sandwich’ in atomic detail, giving the field a structure to develop even better antibodies.
“The drug bound to the KRAS peptide sticks out like a sore thumb, which the antibody then grabs,” said Verba, who like Craik is a member of UCSF’s Quantitative Biosciences Institute (QBI). “We’ve taken a significant step toward patient-specific radiation therapies, which could lead to a new paradigm for treatment.”
Reference: “Therapeutic Targeting and Structural Characterization of a Sotorasib-Modified KRAS G12C–MHC I Complex Demonstrate the Antitumor Efficacy of Hapten-Based Strategies” by Apurva Pandey, Peter J. Rohweder, Lieza M. Chan, Chayanid Ongpipattanakul, Dong hee Chung, Bryce Paolella, Fiona M. Quimby, Ngoc Nguyen, Kliment A. Verba, Michael J. Evans and Charles S. Craik, 15 January 2025, Cancer Research.
DOI: 10.1158/0008-5472.CAN-24-2450
Authors: In addition to Craik, Evans, and Verba, other UCSF authors are Apurva Pandey, PhD, Peter J. Rohweder, PhD, Lieza M. Chan, Chayanid Ongpipattanakul, PhD, Dong hee Chung, PhD, Bryce Paolella, Fiona M. Quimby, Ngoc Nguyen, MS.
Funding and disclosures: This work was supported by the NIH (T32 GM 064337, P41-GM103393, S10OD020054, S10OD021741, and S10OD026881), the UCSF Innovation Ventures Philanthropy Fund, the UCSF Marcus Program in Precision Medicine, and the Howard Hughes Medical Institute.
Craik, Evans, and Rohweder are inventors on a patent application covering part of this work and owned by UCSF. Craik, Ongpipattanakul, and Rohweder are inventors on a patent application related to this technology owned by UCSF. Craik and Rohweder are co-founders and shareholders of Hap10Bio and Evans and Paolella are shareholders of Hap10Bio.
News
New nanoparticles stimulate the immune system to attack ovarian tumors
Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian [...]
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
